Estimaciones de analistas de Wall Street para NeuroOne Medical Technologies Corporation (NMTC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-15 | $-0.22 | ||
| 2026-08-13 | $-0.23 | $-0.21 | -9.5% |
| 2026-05-12 | $-0.25 | $-0.23 | -10.3% |
| 2026-02-17 | $-0.17 | $-0.24 | +29.2% |
| 2025-12-17 | $-0.30 | $-0.24 | -25.0% |
| 2025-08-14 | $-0.18 | $-0.30 | +40.0% |
| 2025-05-13 | $-0.42 | $-0.54 | +22.2% |
| 2025-02-12 | $0.36 | $-0.60 | +160.0% |
Ratios de valoración
| Precio / Valor contable | 3.38 |
| EV / EBITDA | -1.84 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $1.9M | $178146 | $171169 | $2.0M | $3.5M | $12.1M |
| Coste de Ventas | $7740 | $17633 | $21667 | $27569 | $70552 | $275895 | $241963 | $1.5M | $2.4M | $4.0M |
| Beneficio Bruto | -$7740 | -$17633 | -$21667 | -$27569 | $1.9M | -$97749 | -$70794 | $456517 | $1.1M | $8.1M |
| I+D | 0 | $735333 | $951064 | $1.5M | $2.1M | $3.9M | $4.9M | $6.9M | $5.1M | $5.0M |
| Generales y Administrativos | $32611 | $2.3M | $3.5M | $4.3M | $4.8M | $6.3M | $7.0M | $6.9M | $7.9M | $7.4M |
| Gastos Operativos | $32611 | $3.1M | $3.2M | $5.8M | $6.8M | $10.1M | $10.0M | $12.4M | $13.0M | $12.4M |
| Beneficio Operativo | -$32611 | -$3.1M | -$3.2M | -$5.8M | -$4.9M | -$10.2M | -$10.0M | -$12.0M | -$11.9M | -$4.2M |
| EBITDA | -$32611 | -$3.1M | -$4.1M | -$5.8M | -$4.9M | -$9.8M | -$9.9M | -$11.7M | -$11.8M | -$3.0M |
| Gastos por Intereses | 0 | $1.4M | 0 | $284557 | $7.5M | $3053 | 0 | 0 | $228988 | $334063 |
| Beneficio Antes de Impuestos | -$32611 | -$5.1M | -$6.8M | -$6.8M | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| Impuestos | $15164 | 0 | $3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$47775 | -$5.1M | -$6.8M | -$6.8M | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| BPA | $-0.17 | $-13.80 | $-14.58 | $-10.32 | $-15.12 | $-5.58 | $-3.78 | $-3.90 | $-2.76 | $-0.54 |
| BPA Diluido | $-0.17 | $-13.80 | $-14.58 | $-10.32 | $-15.12 | $-5.58 | $-3.78 | $-3.90 | $-2.76 | $-0.54 |
| Acciones en Circulación (Diluidas) | $281833 | $367226 | $467807 | $658754 | $902563 | $1.8M | $2.7M | $3.0M | $4.5M | $6.7M |
Precio
| Precio | $1.41 |
| Capitalización | $12M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ATHE · BDMD · CTSO · ECOR · HYPD · MYO · RBOT
Explorar sector: Healthcare · Medical - Devices
Más secciones de NMTC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones